Quantitative analysis of markers of podocyte injury in the rat puromycin aminonucleoside nephropathy model

Experimental and Toxicologic Pathology

Volumn 67, Issue 2, 2015, Pages 171-177

  Kakimoto, Tetsuhiro ^a   Okada, Kinya ^a   Fujitaka, Keisuke ^a   Nishio, Masashi ^a   Kato, Tsuyoshi ^b   Fukunari, Atsushi ^a   Utsumi, Hiroyuki ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Automated image analysis; Kidney; Laser microdissection; Podocyte; Puromycin aminonucleoside; Enolase

Indexed keywords

BETA ENOLASE; DESMIN; ENOLASE; MESSENGER RNA; PODOCIN; PODOPLANIN; SYNAPTOPODIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; PUROMYCIN AMINONUCLEOSIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOMATION; CELL DAMAGE; CONTROLLED STUDY; GENE EXPRESSION; HISTOPATHOLOGY; IMAGE ANALYSIS; IMMUNOREACTIVITY; KIDNEY DISEASE; LASER MICRODISSECTION; MALE; NONHUMAN; PODOCYTE; PODOPLANIN GENE; QUANTITATIVE ANALYSIS; RAT; RETROSPECTIVE STUDY; SYNAPTOPODIN GENE; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; FLUORESCENCE MICROSCOPY; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASES; MALE; MICROSCOPY, FLUORESCENCE; PODOCYTES; PUROMYCIN AMINONUCLEOSIDE; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 84940166856     PISSN: 09402993     EISSN: 16181433     Source Type: Journal    
DOI: 10.1016/j.etp.2014.11.007     Document Type: Article

References (20)

1. Breiteneder-Geleff S., Matsui K., Soleiman A., et al. Podoplanin, novel 43-kD membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am J Pathol 1997, 151(4):1141-1152.
2. Doleshal M., Magotra A.A., Choudhury B., et al. Evaluation and validation of total RNA extraction methods for microRNA expression analyses in formalin-fixed, paraffin-embedded tissues. J Mol Diagn 2008, 10(3):203-211.
3. Feo S., Antona V., Barbieri G., et al. Transcription of the human β enolase gene (ENO-3) is regulated by an intronic muscle-specific enhancer that binds myocyte-specific enhancer factor 2 proteins and ubiquitous G-rich-box binding factors. Mol Cell Biol 1995, 15(11):5991-6002.
4. Floege J., Alpers C.E., Sage E.H., et al. Markers of complement-dependent and complement-independent glomerular visceral epithelial cell injury in vivo. Expression of antiadhesive proteins and cytoskeletal changes. Lab Invest 1992, 67(4):486-497.
5. Haimoto H., Takashi M., Koshikawa T., et al. Enolase isozymes in renal tubules and renal cell carcinoma. Am J Pathol 1986, 124(3):488-495.
6. Herrmann A., Tozzo E., Funk J. Semi-automated quantitative image analysis of podocyte desmin immunoreactivity as a sensitive marker for acute glomerular damage in the rat puromycin aminonucleoside nephrosis (PAN) model. Exp Toxicol Pathol 2012, 64(1-2):45-49.
7. Hirohashi Y., Relator R., Kakimoto T., et al. Automated quantitative image analysis of glomerular desmin immunostaining as a sensitive injury marker in Spontaneously Diabetic Torii rats. J Biomed Imaging Process 2014, 1(1):20-28. http://www.bowenpublishing.com/jbip/paperInfo.aspx?PaperID=15652.
8. Hoshi S., Shu Y., Yoshida F., et al. Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats. Lab Invest 2002, 82(1):25-35.
9. Kakimoto T., Kimata H., Iwasaki S., et al. Automated recognition and quantification of pancreatic islets in Zucker diabetic fatty rats treated with exendin-4. J Endocrinol 2013, 216(1):13-20.
10. Kakimoto T., Okada K., Hirohashi Y., et al. Automated image analysis of a glomerular injury marker desmin in spontaneously diabetic Torii rats treated with losartan. J. Endocrinol 2014, 222(1):43-51.
11. Kawachi H., Koike H., Kurihara H., et al. Cloning of rat homologue of podocin: expression in proteinuric states and in developing glomeruli. J Am Soc Nephrol 2003, 14(1):46-56.
12. Li Y., Kang Y.S., Dai C., et al. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol 2008, 172(2):299-308.
13. Liu Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 2010, 21(2):212-222.
14. Pavenstädt H., Kriz W., Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 2003, 83(1):253-307.
15. Prasad K., Prabhu G.K. Image analysis tools for evaluation of microscopic views of immunohistochemically stained specimen in medical research-a review. J Med Syst 2012, 36(4):2621-2631.
16. Sofue T., Kiyomoto H., Kobori H., et al. Early treatment with olmesartan prevents juxtamedullary glomerular podocyte injury and the onset of microalbuminuria in type 2 diabetic rats. Am J Hypertens 2012, 25(5):604-611.
17. Specht K., Richter T., Müller U., et al. Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue. Am J Pathol 2001, 158(2):419-429.
18. Wiggins R.C. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 2007, 71(12):1205-1214.
19. Yanagida-Asanuma E., Asanuma K., Kim K., et al. Synaptopodin protects against proteinuria by disrupting Cdc42:IRSp53:Mena signaling complexes in kidney podocytes. Am J Pathol 2007, 171(2):415-427.
20. Zou J., Yaoita E., Watanabe Y., et al. Upregulation of nestin, vimentin, and desmin in rat podocytes in response to injury. Virchows Arch 2006, 448(4):485-492.